Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 104,022 ordinary shares between June 29 and July 3, 2026, for a total consideration of €2.73 million. The average price paid per share was €26.24, increasing the company's holdings of its own ordinary shares to 303,756 as of July 3.
Key figures
- Avg price eur
- 26.24
- Treasury shares
- 303756
- Shares repurchased
- 104022
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.